Beamtree Holdings Limited (ASX:BMT – Get Rating) insider Michael (Mike) Hill bought 52,245 shares of Beamtree stock in a transaction dated Thursday, March 9th. The stock was acquired at an average price of A$0.28 ($0.19) per share, with a total value of A$14,785.34 ($9,856.89).
Beamtree Price Performance
The company has a debt-to-equity ratio of 1.99, a current ratio of 0.83 and a quick ratio of 1.49.
Get
Beamtree alerts:
About Beamtree
(Get Rating)
Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data.
Featured Articles
- Dollar General Offers Great Prices, but the Stock isn't a Value
- Jabil Inc.: Blue Chip Tech Stock Pulls Back To Buy Zone
- Should You Bring The Luck Of The Irish To Your Investmets?
- The Big Banks Join Forces to Save First Republic Bank
- Don't Miss Out: $2 Trillion Could be Headed to the Banking Sector
Receive News & Ratings for Beamtree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beamtree and related companies with MarketBeat.com's FREE daily email newsletter.
Beamtree Holdings Limited(澳大利亞證券交易所代碼:BMT-GET Rating)內部人士邁克爾·Mike·希爾在一筆日期為3月9日星期四的交易中購買了52,245股Beamtree股票。該股的收購均價為每股0.28澳元(0.19美元),總價值為14,785.34澳元(9,856.89美元)。
波束樹性價比
該公司的債務權益比為1.99,流動比率為0.83,速動比率為1.49。
到達
波束樹警報:
關於Beamtree
(獲取評級)
Beamtree Holdings Limited向澳大利亞和國際醫療行業開發和商業化臨床決策支持(CDS)系統。該公司提供RippleDown Expert,這是一種CDS系統,提供即時患者監測和警報解決方案;RippleDown Auditor,自動即時審查數據,確保數據輸入、賬單、樣本接收和標記可疑錯誤的準確性;以及Picq,這是一種用於公立和私立醫院、衛生服務和州衛生部門的編碼質量評估工具,用於評估和報告臨床編碼數據。
專題文章
- 美元通用提供了很好的價格,但股票不是價值
- 捷普公司:藍籌股科技股回落至買入區
- 你應該把愛爾蘭人的幸運帶給你的投資者嗎?
- 大銀行聯手拯救First Republic Bank
- 不要錯過預期:2萬億美元可能流向銀行業
接受Beamtree Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Beamtree和相關公司的最新新聞和分析師評級的每日簡要摘要。